Acticor Biotech SAS
Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France. Show More...
-
Website https://acticor-biotech.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.25 EUR
-
Last Updated 05-03-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 71.49 0.49 0.67 0.5 -0.29 -0.41 -0.14 -3.13 -1.75 -1.16 -1.16 Dividends EUR Payout Ratio % * Shares Mil 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 Book Value Per Share * EUR 0.61 5.36 5.64 5.94 5.34 5.07 2.58 1.77 0.14 -1.02 Free Cash Flow Per Share * EUR 83.87 0.37 0.15 -0.42 -0.15 -1.07 -0.27 -0.12 -0.33 Return on Assets % 5.95 11.64 8.88 5.41 -3.01 -4.41 -1.61 -46.82 -47.95 -59.48 -59.48 Financial Leverage (Average) 3.51 1.39 1.62 1.69 1.7 1.76 1.71 2.5 18.23 18.23 Return on Equity % 20.89 19.06 13.45 8.97 -5.1 -7.62 -2.8 -90.45 -172.26 Return on Invested Capital % 9.56 15.26 12.1 8.26 -4.09 -5.85 -1.78 -69.86 -89.52 Interest Coverage -8.95 -2.71 -153.69 -33.61 -33.61 Current Ratio 2.07 3.47 1.79 1.21 1.85 1.6 1.43 1.11 2.11 0.25 2.11 Quick Ratio 1.96 3.44 1.77 1.17 1.81 1.58 1.27 1.0 1.8 0.24 1.8 Debt/Equity 1.19 0.13 0.1 0.2 0.26 0.22 0.49 6.49 6.49